We are the lung research center of the Leibniz Association. Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
The program area is dedicated to research into asthma, COPD and allergies, as these are among the most common chronic diseases and therefore cause an enormous burden for both patients and healthcare systems.
The Infections program area is dedicated to researching and combating bacterial infectious diseases of the lung with a focus on tuberculosis. The aim is to improve the control and treatment of this disease.
Der ehemalige Direktor der Abteilung Immunologie und Zellbiologie am FZB, Prof. Dr. med. Hans-Dieter Flad, ist im Juli im Alter von 91 Jahren verstorben. Er hat die Geschicke des FZB nach der Neuordnung durch den Wissenschaftsrat fast zwei Jahrzehnte entscheidend mitgeprägt.
06.08.2026
Routine Targeted Next-Generation Sequencing Begins in Namibia
First Tuberculosis Samples Arrive in the Sequencing Lab
Targeted Next-Generation Sequencing (tNGS), endorsed by the World Health Organization since 2023, can help close critical gaps in the diagnosis of drug-resistant tuberculosis (DR-TB). The technology enables the rapid and comprehensive detection of genetic mutations in the bacterium Mycobacterium tuberculosis that cause resistance to antibiotics. By identifying these resistance-conferring mutations early, clinicians
28.07.2026
Broad coalition to combat drug-resistant tuberculosis in Europe
Tuberculosis remains the world’s deadliest infectious disease caused by a single pathogen. In 2024, an estimated 10.7 million people worldwide developed tuberculosis, and 1.23 million died from the disease. The situation is particularly critical for drug-resistant tuberculosis: only around two in five affected individuals had access to treatment in 2024. Moreover, treatment outcomes remain substantially poorer than for drug-susceptible tuberculosis.
Prof. Dr. Andra Schromm
FG Gruppe_en: Immunobiophysics
Contact
Email:
This email address is being protected from spambots. You need JavaScript enabled to view it.